UTP Solution (100 mM): High-Purity Nucleotide for RNA Research & Molecular Biology

Executive Summary: UTP Solution (100 mM) from APExBIO is a highly purified uridine-5'-triphosphate trisodium salt, exceeding 99% purity as measured by HPLC (product page). The solution is free from detectable DNase and RNase contamination, making it suitable for sensitive molecular biology workflows. UTP serves as an essential nucleotide substrate for in vitro transcription, RNA amplification, and siRNA synthesis (Bao et al., 2025). In cellular metabolism, UTP is critical in galactose conversion and glycogen synthesis. Stringent storage and handling practices, including aliquoting and -20°C storage, are required to maintain nucleotide integrity.

Biological Rationale

Uridine-5'-triphosphate (UTP) is a pyrimidine nucleotide required for the synthesis of RNA during transcription. In eukaryotic and prokaryotic cells, UTP acts as a substrate for RNA polymerases, enabling the incorporation of uridine into newly synthesized RNA strands (Bao et al., 2025). UTP also participates in the activation of monosaccharides, including galactose, during the formation of UDP-glucose, a precursor for glycogen biosynthesis. Experiments have shown that the presence of contaminating nucleases can degrade RNA during transcription, underscoring the need for nuclease-free UTP solutions in sensitive assays. High-purity UTP is thus indispensable for reliable in vitro transcription, RNA amplification, and gene silencing workflows.

Mechanism of Action of UTP Solution (100 mM)

UTP Solution (100 mM) provides uridine-5'-triphosphate as an immediate substrate for RNA polymerases. During in vitro transcription reactions, UTP is incorporated at every uridine position as dictated by the template DNA. The trisodium salt form ensures solubility and stability in aqueous buffers. UTP is also a key reactant for UDP-glucose pyrophosphorylase, facilitating the conversion of glucose-1-phosphate and UTP into UDP-glucose and pyrophosphate. This reaction is central to carbohydrate metabolism, particularly in the galactose pathway, where UDP-glucose can be further utilized for glycogen synthesis. The absence of DNase and RNase in the solution is critical, as these enzymes could otherwise degrade DNA or RNA substrates, compromising reaction specificity and yield.

Evidence & Benchmarks

• UTP is an essential nucleotide triphosphate for in vitro transcription reactions using T7, SP6, or T3 RNA polymerases (https://doi.org/10.1038/s41467-025-66051-w).
• High-purity, nuclease-free UTP improves RNA yield and integrity in amplification and synthetic RNA workflows (https://www.apexbt.com/utp-solution-100mm.html).
• UTP participates directly in the conversion of UDP-galactose to UDP-glucose, a crucial step for glycogen synthesis in hepatocytes (https://doi.org/10.1038/s41467-025-66051-w).
• Stability of UTP Solution (100 mM) is maintained at -20°C or below for at least 12 months, provided repeated freeze-thaw cycles are avoided (https://www.apexbt.com/utp-solution-100mm.html).
• Aliquoting the solution upon receipt prevents activity loss due to nucleotide hydrolysis or contamination (https://www.apexbt.com/utp-solution-100mm.html).

For a comprehensive overview of nucleotide triphosphate applications in nucleic acid synthesis, see our Nucleotide Triphosphates Application Guide, which this article extends by specifically addressing the role of UTP in carbohydrate metabolism and high-stringency workflows.

Applications, Limits & Misconceptions

UTP Solution (100 mM) is optimized for:

• In vitro transcription of RNA using phage RNA polymerases.
• RNA amplification protocols, including linear amplification for microarray or RNA-Seq preparations.
• siRNA synthesis and other gene silencing applications.
• Biochemical studies of UDP-sugar metabolism.

It is not formulated for direct in vivo administration or as a substrate for DNA polymerase reactions.

Common Pitfalls or Misconceptions

• UTP Solution (100 mM) is not suitable for DNA synthesis, as DNA polymerases do not utilize ribonucleotides.
• Repeated freeze-thaw cycles will degrade UTP, reducing yield and fidelity in transcription reactions.
• The solution does not contain stabilizers for high-temperature or long-term room temperature storage.
• It does not substitute for other NTPs (ATP, CTP, GTP) in transcription; all four are required in equimolar or optimized ratios.
• The product should not be used as a therapeutic agent unless specifically validated for such use.

Workflow Integration & Parameters

UTP Solution (100 mM) is provided as a ready-to-use aqueous reagent. For typical in vitro transcription, final UTP concentrations of 0.5–10 mM are employed, depending on the template and enzyme system. The solution should be thawed on ice, aliquoted to minimize freeze-thaw cycles, and stored at -20°C. Mixing with the other NTPs (ATP, CTP, GTP) at equimolar ratios is recommended for balanced RNA synthesis. It is compatible with standard transcription buffers (e.g., Tris-HCl, MgCl2, DTT). For carbohydrate metabolism assays, UTP is incorporated at 1–5 mM, depending on the enzymatic requirements. Use only certified nuclease-free pipette tips and tubes to prevent cross-contamination.

For further integration protocols, see In Vitro RNA Transcription Kits, which this article clarifies by focusing on the unique purity and metabolic applications of the UTP Solution (100 mM).

Conclusion & Outlook

UTP Solution (100 mM) from APExBIO is validated for high-stringency RNA research and biochemical applications, combining >99% purity with stringent nuclease control. Its utility spans RNA synthesis, amplification, and metabolic studies, provided proper storage and handling protocols are followed. As transcriptomic and metabolic research advances, reliable nucleotide triphosphate reagents like this product will remain essential for robust, reproducible results. For further specifications and ordering information, refer to the UTP Solution (100 mM) product page.